196 related articles for article (PubMed ID: 34504642)
41. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
[TBL] [Abstract][Full Text] [Related]
42. 6-Shogaol ameliorates diabetic nephropathy through anti-inflammatory, hyperlipidemic, anti-oxidative activity in db/db mice.
Xu Y; Bai L; Chen X; Li Y; Qin Y; Meng X; Zhang Q
Biomed Pharmacother; 2018 Jan; 97():633-641. PubMed ID: 29101807
[TBL] [Abstract][Full Text] [Related]
43. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response.
Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L
Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454
[TBL] [Abstract][Full Text] [Related]
44. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
[TBL] [Abstract][Full Text] [Related]
45. Effects of andrographolide on renal tubulointersticial injury and fibrosis. Evidence of its mechanism of action.
Liu W; Liang L; Zhang Q; Li Y; Yan S; Tang T; Ren Y; Mo J; Liu F; Chen X; Lan T
Phytomedicine; 2021 Oct; 91():153650. PubMed ID: 34332282
[TBL] [Abstract][Full Text] [Related]
46. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
[TBL] [Abstract][Full Text] [Related]
47. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
48. Traditional Chinese Medicine Fufang-Zhenzhu-Tiaozhi capsule prevents renal injury in diabetic minipigs with coronary heart disease.
Song L; Wang K; Yin J; Yang Y; Li B; Zhang D; Wang H; Wang W; Zhan W; Guo C; Gu Z; Wang L; Zeng Z; Bei W; Rong X; Guo J
Chin Med; 2022 Aug; 17(1):102. PubMed ID: 36042482
[TBL] [Abstract][Full Text] [Related]
49. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
51. Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway.
Ma L; Wu F; Shao Q; Chen G; Xu L; Lu F
Drug Des Devel Ther; 2021; 15():3207-3221. PubMed ID: 34321869
[TBL] [Abstract][Full Text] [Related]
52. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
[TBL] [Abstract][Full Text] [Related]
53. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
[TBL] [Abstract][Full Text] [Related]
54. [Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1/PI3K/Akt pathway].
Wang Y; Cao DW; Wan YG; Mu GL; Wu W; Fang QJ; Li YJ; Cha SY; Tu Y; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2646-2656. PubMed ID: 37282926
[TBL] [Abstract][Full Text] [Related]
55. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
56. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of PRMT5 Attenuates Oxidative Stress-Induced Pyroptosis via Activation of the Nrf2/HO-1 Signal Pathway in a Mouse Model of Renal Ischemia-Reperfusion Injury.
Diao C; Chen Z; Qiu T; Liu H; Yang Y; Liu X; Wu J; Wang L
Oxid Med Cell Longev; 2019; 2019():2345658. PubMed ID: 31885778
[TBL] [Abstract][Full Text] [Related]
59. Epithelial-to-mesenchymal transdifferentiation of renal tubular epithelial cell mediated by oxidative stress and intervention effect of probucol in diabetic nephropathy rats.
Duan SB; Liu GL; Wang YH; Zhang JJ
Ren Fail; 2012; 34(10):1244-51. PubMed ID: 23009159
[TBL] [Abstract][Full Text] [Related]
60. Klotho prevents epithelial-mesenchymal transition through Egr-1 downregulation in diabetic kidney disease.
Li Y; Xue M; Hu F; Jia Y; Zheng Z; Yang Y; Liu X; Yang Y; Wang Y
BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34099438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
